Concepedia

Author

Nichola Cooper

Imperial College LondonORCID

Also Known As

A Cooper, Allen Cheng, Anita Chandra, Carole Brewer, Clio Pillay, Cooper, N., Cooper,Nichola, J Corcoran, Jenny Chambers, John Davis

317

Publications

18.4K

Citations

60

H-Index

88

Concepts

All Affiliations

Imperial College LondonHammersmith HospitalCornell UniversityUniversity College LondonImperial College Healthcare NHS Trust
NC

About

Nichola Cooper is an author at Imperial College London specializing in medicine, immunology, and autoimmunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

26

2.5K

2

Health Sciences

9

9

842

3

Allergy

2

2

145

4

Blood Transplantation

2

2

29

5

Public Health

1

1

107

Nichola Cooper

×

88

Publications

13.1K

Citations

45

H-Index

YearCitations

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer,

Blood

2008

2.6K

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold,

Blood Advances

2019

1.2K

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters,

New England Journal of Medicine

2021

1.1K

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Drew Provan, Donald M. Arnold, James B. Bussel,

Blood Advances

2019

1K

Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease

Keren Carss, Gavin Arno, Marie Erwood,

The American Journal of Human Genetics

2016

463

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab

Roberto Stasi, Nichola Cooper, Giovanni Del Poeta,

Blood

2008

402

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Vivek Patel, Matthieu Mahévas, Soo Yong Lee,

Blood

2012

337

The efficacy and safety of B‐cell depletion with anti‐CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

Nichola Cooper, Roberto Stasi, Susanna Cunningham–Rundles,

British Journal of Haematology

2004

334

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

James B. Bussel, Donald M. Arnold, Elliot Grossbard,

American Journal of Hematology

2018

329

Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

Roberto Stasi, Giovanni Del Poeta, Elisa Stipa,

Blood

2007

294

Page 1